Background: Prospective studies of dietary magnesium intake in relation to risk of stroke have yielded inconsistent results. Objective: We conducted a dose-response meta-analysis to summarize the evidence regarding the association between magnesium intake and stroke risk. Design: Relevant studies were identified by searching PubMed and EMBASE from January 1966 through September 2011 and reviewing reference lists of retrieved articles. We included prospective studies that reported RRs with 95% CIs of stroke for 3 categories of magnesium intake. Results from individual studies were combined by using a random-effects model. Results: Seven prospective studies, with 6477 cases of stroke and 241,378 participants, were eligible for inclusion in the meta-analysis. We observed a modest but statistically significant inverse association between magnesium intake and risk of stroke. An intake increment of 100 mg Mg/d was associated with an 8% reduction in risk of total stroke (combined RR: 0.92; 95% CI: 0.88, 0.97), without heterogeneity among studies (P = 0.66, I 2 = 0%). Magnesium intake was inversely associated with risk of ischemic stroke (RR: 0.91; 95% CI: 0.87, 0.96) but not intracerebral hemorrhage (RR: 0.96; 95% CI: 0.84, 1.10) or subarachnoid hemorrhage (RR: 1.01; 95% CI: 0.90, 1.14). Conclusion: Dietary magnesium intake is inversely associated with risk of stroke, specifically ischemic stroke.
INTRODUCTION
Dietary magnesium intake has been inversely associated with risk factors for stroke such as hypertension (1, 2) , metabolic syndrome (3), and type 2 diabetes (2, 4) . Randomized clinical trials have shown that magnesium supplementation modestly reduces diastolic blood pressure (5) as well as fasting C-peptide and insulin concentrations (6) . Furthermore, findings from animal studies have shown that high-magnesium diets have favorable effects on plasma glucose and blood lipid concentrations (7) , and magnesium deficiency increases the susceptibility of lipoproteins to peroxidation (8) . Hence, a high dietary magnesium intake may potentially reduce risk of stroke.
To our knowledge, the epidemiologic evidence on the relation between dietary magnesium intake and risk of stroke has not yet been summarized. Therefore, we performed a systematic review and dose-response meta-analysis to assess the association between magnesium intake and risk of total stroke and stroke subtypes.
METHODS

Literature search and selection
We followed standard criteria for conducting and reporting of meta-analyses of observational studies (9) . We conducted a literature search of PubMed (http://www.ncbi.nlm.nih.gov/ pubmed) and EMBASE (http://www.embase.com) from January 1966 through September 2011 by using the key words "magnesium intake" combined with "stroke." In addition, we reviewed reference lists of retrieved articles to identify additional relevant studies. No language restrictions were imposed.
Studies were included in this meta-analysis if they fulfilled the following criteria: 1) had a prospective design, 2) the exposure of interest was magnesium intake, 3) the outcome was stroke, and 4) the studies reported RRs with 95% CIs for 3 quantitative categories of magnesium intake. RRs had to at least be adjusted for age and sex (if applicable).
Data extraction
The following data were extracted from each study: first author's last name, publication year, name of the cohort study, study location, years of follow-up, sex, age, sample size (number of cases and total number of participants), magnesium intake categories, covariates adjusted for in the multivariable analysis, and RRs with their 95% CIs for each category of magnesium intake. We extracted RRs that reflected the greatest degree of adjustment for potential confounders. Data extraction was conducted independently by 2 investigators (SCL and NO) with disagreements resolved by consensus.
Statistical analysis
Because the range of magnesium intake and the cutoffs for the categories differed between studies, we estimated an RR with 95% CI for an increase in intake of 100 mg Mg/d for each study. We used the method proposed by Greenland and Longnecker (10) and Orsini et al (11) to compute the trend from the correlated log RR estimates across categories of magnesium intake. For each study, the median or mean magnesium intake for each category was assigned to each corresponding RR. When the median or mean intake per category was not provided, we assigned the midpoint of upper and lower boundaries in each category as the average intake. If the lower or upper boundary for the lowest and highest category, respectively, was not reported, we assumed that the boundary had the same amplitude as the closest category.
To examine a potential nonlinear association between magnesium intake and stroke risk, we performed a 2-stage, random-effects, dose-response meta-analysis. This was done by modeling magnesium intake by using restricted cubic splines with 3 knots at fixed percentiles 10%, 50%, and 90% of the distribution (12) . First, a restricted cubic-spline model was estimated by using generalized least-square regression and taking into account the correlation within each set of published RRs as described by Orsini et al (11) . Second, we combined the study-specific estimates by using the restricted maximum likelihood method in a multivariate random-effects metaanalysis (13) . A P value for nonlinearity was calculated by testing the null hypothesis that the coefficient of the second spline was equal to zero. We showed no significant departure from a linear-response model (P-spline transformation = 0.15).
Statistical heterogeneity among studies was evaluated by using I 2 statistics (14) . Three cutoffs of these I 2 values were considered as follows: ,30% (no or marginal between-study heterogeneity), 30-75% (mild heterogeneity), and .75% (notable heterogeneity). We performed analyses stratified by study location and stroke subtypes. Publication bias was assessed with Egger's regression test (15) . All statistical analyses were conducted with Stata software (version 10.1; StataCorp). P , 0.05 was considered statistically significant.
RESULTS
Study characteristics
Our literature search identified 7 independent prospective studies of dietary magnesium intake and stroke risk ( Figure 1) (2, 3, (16) (17) (18) (19) (20) . The studies were published between 1998 and 2011 and included a total of 6477 stroke cases and 241,378 participants ( Table 1) . Four studies were conducted in the United States, 2 studies were conducted in Europe, and one study was conducted in Taiwan. The median magnesium intake in the study populations ranged from 242 mg/d (in US men and women) to 471 mg/d (in Finnish men). All studies provided risk estimates that were adjusted for age, smoking, and BMI. Most studies also controlled for physical activity (6 studies), diabetes (6 studies), history of hypertension or measured blood pressure (6 studies), and alcohol consumption (6 studies); fewer studies adjusted for other nutrients (3 studies).
Magnesium intake and stroke
Estimated RRs of total stroke for an increase in intake of 100 mg Mg/d for each of the included studies and the combined estimate are shown in Figure 2 . The combined RR of total stroke was 0.92 (95% CI: 0.88, 0.97) without heterogeneity among studies (P = 0.66, I 2 = 0%). In a sensitivity analysis in which one study at the time was omitted and the rest of studies were analyzed, combined RRs ranged from 0.91 (95% CI: 0.85, 0.97) to 0.93 (95% CI: 0.88, 0.99). Hypertension and diabetes were potential confounders of the association between magnesium intake and stroke risk. The results persisted when we excluded the study (17) that did not adjust for both hypertension and diabetes (RR: 0.92; 95% CI: 0.87, 0.98). We showed no evidence of publication bias (Egger's test: P = 0.54).
Combined RRs of stroke for an increment in intake of 100 mg Mg/d were 0.91 (95% CI: 0.85, 0.96) in studies conducted in the United States and 0.95 (95% CI: 0.88, 1.02) in the European studies. Four studies provided results for stroke subtypes (3, 17, 18, 20) and 2 studies reported results for ischemic stroke only (2, 19) . For these 6 studies, combined RRs for an increase in intake of 100 mg Mg/d were 0.91 (95% CI: 0.87, 0.96) for ischemic stroke, 0.96 (95% CI: 0.84, 1.10) for intracerebral hemorrhage, and 1.01 (95% CI: 0.90, 1.14) for subarachnoid hemorrhage.
DISCUSSION
This meta-analysis of 7 prospective studies showed a significant inverse association between dietary magnesium intake and risk of stroke. An increase in intake of 100 mg Mg/d was associated with an 8% and 9% decreased risk of total stroke and ischemic stroke, respectively. Magnesium intake was not associated with hemorrhagic strokes. However, the number of cases was lower for hemorrhagic stroke than for ischemic and total strokes, which led to a lower statistical power to estimate the association between magnesium intake and risk of hemorrhagic stroke.
Rich food sources of magnesium are green leafy vegetables, nuts, beans, and whole grains. The US Recommended Dietary Allowance of magnesium for women and men 31-70 y of age is Age, education, smoking, BMI, physical activity, history of diabetes, history of hypertension, aspirin use, family history of myocardial infarction, and intakes of alcohol, protein, cholesterol, total fiber, folate, and total energy 320 and 420 mg/d, respectively (21) . The approximate magnesium content of some foods is 157 mg in 1 cup cooked spinach, 77 mg in 1 oz roasted cashew nuts, 134 mg in 1 cup canned white beans, 88 mg in 1 cup cooked oat bran, and 84 mg in 1 cup cooked brown rice (22) . There are several potential mechanisms by which magnesium may reduce risk of ischemic stroke. The protective effect of magnesium against risk of stroke may in part be related to its blood pressure-lowering effect. Findings from a meta-analysis of 12 randomized clinical trials (median follow-up: 11 wk) showed that magnesium supplementation (mean dose: ;400 mg/d) may slightly decrease diastolic blood pressure by 2.2 mm Hg (5) . Most studies included in this meta-analysis controlled for history of hypertension or blood pressure levels. There may have been overadjustment if the association between magnesium intake and stroke was mediated via a reduction in blood pressure. Magnesium intake has also been inversely associated with risk of type 2 diabetes (2, 4) , which is a risk factor for ischemic stroke (23, 24) . Therefore, it is possible that type 2 diabetes is a mediator of the association between magnesium intake and ischemic stroke. Moreover, a high-magnesium diet has been shown to have favorable effects on plasma glucose and blood lipid concentrations in rats with chronic diabetes (7) . In addition, there are reports that showed that magnesium deficiency increased the susceptibility of lipoproteins to peroxidation in animals (8) .
This meta-analysis had several strengths. First, our quantitative assessment was based on data from prospective studies, which eliminated recall and selection biases. Furthermore, by combining results from several studies, we had high statistical power to estimate the relation between magnesium intake and risk of stroke. Also, all studies were very consistent with no heterogeneity among study results. This meta-analysis also had several potential limitations. First, as a meta-analysis of observational studies, the possibility of confounding as a potential explanation for the observed inverse association between magnesium intake and stroke risk could not be excluded. Although the majority of studies adjusted for known risk factors for stroke, such as age, cigarette smoking, BMI, physical activity, histories of diabetes and hypertension, and alcohol consumption, the possibility for residual confounding remained. Moreover, it could not be excluded that other nutrients or dietary components that are correlated with dietary magnesium may have been responsible, partly or in whole, for the observed association. A second limitation was the misclassification of magnesium intake, which would most likely have led to an underestimation of the true relation between magnesium intake and stroke. Finally, in a metaanalysis of published studies, publication bias may be a problem. However, we showed no evidence of publication bias in this metaanalysis.
In conclusion, results from this meta-analysis indicate that dietary magnesium intake is inversely associated with risk of stroke. Although it is premature to recommend magnesium supplementation to reduce risk of stroke, increased consumption of magnesium-rich foods such as green leafy vegetables, beans, nuts, and whole-grain cereals appears to be prudent.
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